Human tumor microenvironment chip evaluates the consequences of platelet extravasation and combinatorial antitumor-antiplatelet therapy in ovarian cancer
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Platelets extravasate from the circulation into tumor microenvironment, enable metastasis, and confer resistance to chemotherapy in several cancers. Therefore, arresting tumor-platelet cross-talk with effective and atoxic antiplatelet agents in combination with anticancer drugs may serve as an effective cancer treatment strategy. To test this concept, we create an ovarian tumor microenvironment chip (OTME-Chip) that consists of a platelet-perfused tumor microenvironment and which recapitulates platelet extravasation and its consequences. By including gene-edited tumors and RNA sequencing, this organ-on-chip revealed that platelets and tumors interact through glycoprotein VI (GPVI) and tumor galectin-3 under shear. Last, as proof of principle of a clinical trial, we showed that a GPVI inhibitor, Revacept, impairs metastatic potential and improves chemotherapy. Since GPVI is an antithrombotic target that does not impair hemostasis, it represents a safe cancer therapeutic. We propose that OTME-Chip could be deployed to study other vascular and hematological targets in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“They also showed that the administration of GPVI led to reduced cancer proliferation, invasion and chemotherapy resistance.”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Saha et al., 2021
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In a subsequent study with an improved microfluidic chip design integrating a more physiological ECM, Saha et al. explored the effectiveness of a glycoprotein VI (GPVI) inhibitor to limit platelet extravasation (Saha et al., 2021).”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Saha et al., 2021
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Their microfluidic chip revealed that the interaction of platelets and tumors occurs via glycoprotein VI and tumor galectin-3, a protein typically overexpressed in advanced stages of ovarian cancer.”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Saha et al., 2021
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Labelle, M., Begum, S., & Hynes, R. O. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.09.009 · Cited by 1,833
Neutrophils in cancer: Neutral no more
Coffelt, S. B., Wellenstein, M. D., & de Visser, K. E. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.52 · Cited by 1,830
Neutrophils support lung colonization of metastasis-initiating breast cancer cells
Wculek, S. K., & Malanchi, I. (2015) · Nature · doi:10.1038/nature16140 · Cited by 1,003
Three-dimensional microfluidic model for tumor cell intravasation and endothelial barrier function
Zervantonakis, I. K., Hughes-Alford, S. K., Charest, J. L., Condeelis, J. S., Gertler, F. B., & Kamm, R. D. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1210182109 · Cited by 872 · cited 1×
“This relative simplicity and a provision to do analytics is a strength of our OTME-Chip, which is also not radically different from its prior versions (20) and consistent with prior models (39).”
ResultParaneoplastic thrombocytosis in ovarian cancer
Stone, R. L., Nick, A. M., McNeish, I. A., Balkwill, F., Han, H. D., Bottsford-Miller, J., Rupaimoole, R., Armaiz-Pena, G. N., Pecot, C. V., Coward, J., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110352 · Cited by 812
Self-citationMicrofabrication of human organs-on-chips
Huh, D., Kim, H. J., Fraser, J. P., Shea, D. E., Khan, M., Bahinski, A., Hamilton, G. A., & Ingber, D. E. (2013) · Nature Protocols · doi:10.1038/nprot.2013.137 · Cited by 712
Role of platelets and platelet receptors in cancer metastasis
Schlesinger, M. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0669-2 · Cited by 690
The Platelet Lifeline to Cancer: Challenges and Opportunities
Haemmerle, M., Stone, R. L., Menter, D. G., Afshar-Kharghan, V., & Sood, A. K. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.002 · Cited by 638
Self-citationCOSMID: A Web-based Tool for Identifying and Validating CRISPR/Cas Off-target Sites
Cradick, T. J., Qiu, P., Lee, C. M., Fine, E. J., & Bao, G. (2014) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2014.64 · Cited by 408
Self-citationChen, M. B., Whisler, J. A., Fröse, J., Yu, C., Shin, Y., & Kamm, R. D. (2017) · Nature Protocols · doi:10.1038/nprot.2017.018 · Cited by 385
Cited by
Advances in 3D bioprinting of tissues/organs for regenerative medicine and in-vitro models
Jain, P., Kathuria, H., & Dubey, N. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121639 · Cited by 237
The dynamic role of platelets in cancer progression and their therapeutic implications
Li, S., Lu, Z., Wu, S., Chu, T., Li, B., Qi, F., Zhao, Y., & Nie, G. (2024) · Nature Reviews Cancer · doi:10.1038/s41568-023-00639-6 · Cited by 214
Du, Y., Wang, Y., Bao, Q., Xu, X., Xu, C., Wang, S., Liu, Q., Liu, F., Zeng, Y., Wang, Y., et al. (2024) · Advanced Materials · doi:10.1002/adma.202412815 · Cited by 112
From Organ-on-a-Chip to Human-on-a-Chip: A Review of Research Progress and Latest Applications
Huang, Y., Liu, T., Huang, Q., & Wang, Y. (2024) · ACS Sensors · doi:10.1021/acssensors.4c00004 · Cited by 110
Seo, S., Nah, S.-Y., Lee, K., Choi, N., & Kim, H. N. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202106860 · Cited by 94
Metadata
- Authors
- Saha, B., Mathur, T., Tronolone, J. J., Chokshi, M., Lokhande, G. K., Selahi, A., Gaharwar, A. K., Afshar-Kharghan, V., Sood, A. K., Bao, G., & Jain, A.
- Affiliations
- Texas A&M University (US)
- Rice University (US)
- Department of Benign Hematology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
- The University of Texas MD Anderson Cancer Center (US)
- Texas A&M Health Science Center (US)
- Corresponding author
- Jain, Abhishek
- ORCID
- Venue
- Science Advances
- Published
- 2021-07-23
- Volume
- 7
- Issue
- 30
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC8294767
- OpenAlex
- W3185380516
- Cited by
- 90
- References
- 56
- Citations by year
- 2026: 11 · 2025: 22 · 2024: 19 · 2023: 21 · 2022: 15 · 2021: 2
- FWCI
- 4.33
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Science Advances (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Rice Research Repository (Rice University) (submittedVersion, cc-by)
- Funders
- National Science Foundation (1944322)
- National Institutes of Health (R21EB025945, P30 CA016672, P50 CA217685, CA177909, R35 CA209904)
- National Institute of Biomedical Imaging and Bioengineering (R21EB025945)
- UVA Cancer Center (RR140081)
- National Science Foundation Graduate Research Fellowship (1650114)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- tumor microenvironment, ovarian cancer, organ-on-a-chip, glycoprotein VI, galectin-3, shear stress, antiplatelet therapy, metastasis, chemoresistance
- MeSH terms
- Blood Platelets, Humans, Ovarian Neoplasms, Platelet Aggregation Inhibitors, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.